Compare · HIND vs MDLN
HIND vs MDLN
Side-by-side comparison of Vyome Holdings Inc. (HIND) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIND and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 3586.5x HIND ($13.4M).
- MDLN has hit the wire 7 times in the past 4 weeks while HIND has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 1 for HIND).
- Company
- Vyome Holdings Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $13.4M
- $48.08B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2025
- News (4w)
- 0
- 7
- Recent ratings
- 1
- 25
Latest HIND
- Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
- SEC Form 4 filed by Vyome Holdings Inc.
- Chardan Capital Markets initiated coverage on Vyome Holdings with a new price target
- SEC Form 3 filed by new insider Leonard Jerry
- Vyome Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
- SEC Form 10-Q filed by Vyome Holdings Inc.
- Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M